Pulmonology Flashcards

1
Q

Asthma characteristics

A

Chronic inflammation characterized by reversible airway obstruction and bronchospasm

Triggers: allergens, pollution, URI, exercise, beta blockers, aspirin (rare)

Presentation:
Cough
Wheezing
Chest tightness
Dyspnea
Tachypnea
Tachycardia
Prolonged expiratory duration
Decreased breath sounds
Accessory muscle use
Pulses paradoxus
Cyanosis

Labs:
Decreased peak flow, decreased FEV1/FVC ratio
ABG - mild hypoxia, respiratory alkalosis

CXR: hyper inflation - air trapping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Indications for home 02

A

Pulse ox symmetry less than 88%
Pulmonary hypertension
Peripheral edema
Polycythemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

COPD - features, dx, general management all stages

A
Clinical features:
Productive cough
Recurrent respiratory infections
Dyspnea
Wheezing
Rhonchi

FEV1/FVC less than 80% - obstructive lung disease
FEV1/FVC less than 70% - diagnostic of COPD

Tx:
stop smoking
yearly influenza vaccine
Pneumococcal vaccine - 19-65; single vaccine after 65 if more than 5 yrs from initial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

COPD staging

A

GOLD 1: FEV1 > 80% predicted - mild
GOLD 2: FEV1 50-80% - moderate
GOLD 3: FEV1 30-50% - severe
GOLD 4: FEV1 less than 30% - very severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

COPD management - Category A

A

GOLD 1 or 2 with mild or infrequent symptoms
0-1 exacerbations per year

Short acting bronchodilator - albuterol, ipatropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

COPD management - Category B

A

GOLD 1 or 2 with moderate to severe symptoms
-stop to catch breath when walking on level ground, walk slowly

Short acting bronchodilator
Long-acting bronchodilator: B2-agonist or anticholinergic (tiotropium, ipratropium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

COPD management - Category C

A

GOLD 3 or 4 with mild or infrequent symptoms

Short acting bronchodilator
Long acting bronchodilator
inhaled steroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

COPD management - Category D

A

GOLD 3 and 4 with moderate to severe symptoms

Short acting bronchodilator
Long acting bronchodilator
inhaled steroid
\+/- theophylline
Home O2
\+/- phosphodiesterase-4 inhibitor - roflumilast
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Emphysema

A

Destruction of alveoli and bronchioles

  • centriacinar - smoking
  • panacinar - alpha-1-antitrypsin deficiency
Features:
Dyspnea, productive cough, wheezing, rhonchi, decreased breath sounds
Barrel chest, use of accessory muscles
Prolonged expiratory duration
Pursed lip breathing (increases PEEP)
Morning headaches
Decreased heart sounds
JVD

Dx:
PFT: decreased FEV1/FVC, increased total lung capacity - air trapping
ABG: low O2, high CO2 - during exacerbations
CXR: flat diaphragm, hyperinflation, subpleural blebs/bullae, decreased vascular markings
DLCO decreased

Tx:
Stop smoking
Fast acting beta agonist, inhaled anticholinergics, inhaled corticosteroids
Home O2

A1-antitrypsin augmentation -> lung transplant

Complications
Chronic respiratory decompensation
Cor pulmonale
Frequent respiratory infection
Comorbid lung cancer common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chronic bronchitis

A

Productive cough for three months in each of two successive years

Can proceed or follow development of airflow limitation

Tx:
Stop smoking
azithromycin, respiratory fluoroquinolone (levofloxacin), amoxicillin/clavulanate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Etiologies of bronchiectasis

A

Permanent dilation

unknown in 50%
Cystic fibrosis
Immunodeficiency
Dyskinetic cilia: Kartagener syndrome (dextrocardia, sinusitis, bronchiectasis), ADPKD
Pulmonary infections: TB, fungal infection, lung abscess
Obstruction: FB, tumor, LN

Other etiologies: Young syndrome, RA, Sjogen syndrome, allergic bronchopulmonary aspergillosis, smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bronchiectasis

A
features:
Persistent, productive cough
Hemoptysis
Frequent respiratory infections
Dyspnea
copious sputum
wheezing, rales
hypoxemia

CXR: multiple cysts and bronchial crowding
CT: dilation of bronchi, bronchial wall thickening, bronchial wall cysts, dilation and thickening of the airways

Tx:
pulmonary hygiene - hydration, sputum removal
Chest physiotherapy
Abx when sputum production increases
Inhaled b2-agonists and corticosteroids may reduce sxs
Resection of severely diseased regions - hemorrhage, substantial sputum production, inviability

Complications:
Cor pulmonale
Massive hemoptysis
frequent abscess formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Characteristics of malignant pulmonary lesions

A
Smoker
Over 45
New or progress lesion
irregular or asymmetric calcifications
>2 cm
Irregular margins

Get PET, bx, immediate ressection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Characteristics of benign pulmonary lesions

A
Under 35
No change from prior films
Central/uniform lesion with smooth margins
Less than 2 cm
No evidence of LAD

Follow with CXR in 3-6 mo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Adenocarcinoma of lung

A

MC lung cancer, and in nonsmokers and females

Peripheral, on pre-existing parenchymal scars
Associated with smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Large cell carcinoma of lung

A

Peripheral
anaplastic, undifferentiated giant cells
Strongly associated with smoking
Poor prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Squamous cell carcinoma of lung

A

2nd MC type of lung cancer

Central - hilar mass from bronchus
Associated with smoking

Hypercalcemia - paraneoplastic syndrome, PTH-r protein

CXR/CT: cavitated lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Small cell carcinoma of lung

A

Central
Associated with smoking
Paraneoplastic: ACTH (Cushing Sn), ADH (SIADH), antibodies against presynaptic calcium channels (Lambert-Eaton Sn)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pancoast tumor

A

usually non-small cell
Apex of lung
Can compress cervical sympathetic ganglion
-> Horner syndrome (miosis, ptosis, anhidrosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Superior vena cava syndrome

A

Edema/ flushing a face and arms
SOB, dysphagia, HA
Compression by lung tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lung cancer treatments

A

non-small cell - surgical resection if possible, radiation, chemotherapy

Small cell: chemotherapy primarily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Malignant mesothelioma

A

pleura or pericardium
heavily associated with asbestos exposure
No association with smoking

presentation:
Chest pain
Dyspnea
Dullness to percussion
Exudative pleural effusion
Chest wall mass
Tx:
Surgery - pleurectomy, decortication
Radiotherapy
Chemotherapy
Poor prognosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Asbestos exposure cancer risk

A

more likely to get bronchogenic lung cancer than mesothelioma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Laryngeal cancer

A

Associated with tobacco use - smoking, smokeless tobacco; alcohol use

Presentation:
Hoarseness
Dysphasia
Ear pain
hemoptysis

Dx: larygnoscopy with bx

Tx: partial or total laryngectomy, radiation, chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Idiopathic pulmonary fibrosis
Ineffective repair of alveolar epithelial cells injured by smoking, pollutants, microaspirations over 40 yo ``` Presentation: Progressive exercise intolerance Dyspnea Dry crackles JVD Tachypnea Possible digital clubbing ``` PFT: decrease lung volume, normal FEV1/FVC ratio Radiology: honey come appearance - reticular Bx: fibrosis with decreased parenchymal architecture ``` Tx: pirfenidone nintedanib sildenafil Corticosteroids Antibiotics One transplant ``` Only survive 3 to 5 years after diagnosis
26
Sarcoidosis
``` "A GRUELING Disease" ACE elevated in serum Gammaglobulinemia RA Uveitis Erythema nodosum LAD - b/l hilar LAD Idiopathic Noncaseating Grandulomas D vitamin production by activated macrophages in granulomas -> hypercalcemia ``` Pulmonary involvement: cough dyspnea and chest pain Radiology: noncaseating granulomas, b/l hilar LAD, pulmonary infiltrate, skin lesions Tx: Glucocorticoids, cytotoxic drugs, +/- lung transplant Frequently show anergy to skin test or PPD
27
Silicosis
mining, demolition of concrete, stonecutting, sandblastng Upper lobes "eggshell" calcifications of hilar LN Increased susceptibility to TB risk of lung CA increased x2
28
Coal workers disease
mining coal Anthracosis - generally asx or mild -urban dwellers, tobacco smokers Simple coal workers disease - small fibrotic lung nodules Complicated: progressive massive fibrosis and necrosis Presents as chronic bronchitis No increased lung cancer risk, unless radon or smoking exposure
29
Berylliosis
aerospace manufacturing Noncaseating granulomas Increased risk of lung cancer
30
Goodpasture's syndrome
progressive autoimmune disease of lungs and kidneys Anti-glomerular basement membrane Ab ``` Presentation: hemoptysis dyspnea Respiratory infection proteinuria granular casts hematuria ``` Dx: anti-GBM ab Bx: crescentic GN and IgG deposits along glomerular capillaries Tx: plasmapheresis, corticosteroids, immunosuppressive agents
31
Granulomatosis with polyangiitis (Wegner)
Triad: Necrotizing granulomas of the upper and/or lower respiratory tract Necrotizing or granulomatous vasculitis in lungs and upper airways Focal necrotizing, often crescentic, glomerulonephritis ``` Presentation: hemoptysis dyspnea myalgias chronic sinusitis ulcerations of nasopharynx saddle nose deformity ``` c-ANCA ``` Tx: corticosteroids, cyclophosphamide methotrexate rituximab plasma exchange ```
32
A-a gradient
Compares O2 status of alveoli to arterial blood Normal 5-15 increased in PE, pulmonary edema, right to left shunt PAlvO2 - PartO2 713 x 0.21 - (PaCO2/0.8) - PaO2
33
Pulmonary embolism
``` Risk factors: Immobilization Malignancy Recent surgery Pregnancy OCP use Smoking Obesity Fractures Prior DVT Severe burns ``` Presentation: dyspnea, pleuritic chest pain, cough, hemoptysis (rare) DVT symptoms (swollen leg) Abrupt AMS Dx: D dimer - r/o DVT/PE in low probability situations CTA - best test CXR: Hampton's Hump - wedge shaped opacification at distal lung fields; usually normal, may have atelectasis, pleural efusions ABG - elevated A-a gradient ECG - sinus tach - classic but rare: S1Q3T3 V/Q scan - if can't use contrast for CTA -ventilatory defects suggest PNA or other parenchymal lung disease -perfusion defects suggest PE Tx: Unstable - thrombolysis (tPA, streptokinase, urokinase) Stable - anticoagulation -state LMWH, heparin or fondaparinux -> warfarin or rivaroxaban, apixaban, edoxaban or dabigatran
34
Pulmonary hypertension
``` Causes: PE Valvular disease - MS, MR Left to right shunt COPD (MC) Idiopathic ``` Presentation: dypsnea, fatigue, CP, cough, syncope ``` Exam: cyanosis Digital clubbing loud S2 JVD Hepatomegaly ``` Dx: ECG - RVH - cor pulmonale CXR: pulmonary vascular congestion, enlarged RV ECHO or cath to measure pressure Tx: CCB (nifedipine) endothelin receptor antagonists (ambrisentan, bosentan) cGMP phosphodiesterase inhibitors (sildenafil, tadalafil) Prostanoids (ilprost, treprostinil)
35
Pulmonary edema
Increased pulmonary venous pressure -> fluid leaks from vessels into lung interstitial and airspaces ``` Causes: Left-sided heart failure MI Valvular disease Arrhythmias ARDS ``` ``` Features: dyspnea orthopnea paroxysymal noctural dyspnea frothy pink sputum tachycardia +/- wheezing ``` Dx: BNP elevated ECG: T wave abnormalities or QT prolongation CXR: diffuse interstitial fluid, cephalization of the vessels, Kerley B lines Tx: NOLIP Nitrates - redistribute blood outside pulmonary vasculature, decreased preload Oxygen - if hypoxemic Loop diuretics Inotropic drugs - dobutamine, milrinone (not first line, increased mortality) Positioning
36
Pleural effusion
Excess fluid in the pleural space ``` Presentation: Sob, dyspnea with exertion +/- pleuritic chest pain Fatigue dullness to percussion (over 300 ml) Decreased breath sounds Decreased tactile fremitus egophony +/- tracheal deviation ``` CXR: fluid level or blunting of costophrenic angles Transudate: CHF, cirrhosis, nephrotic sn - Pleural to serum protein less than 0.5 - OR- - Pleural to serum LDH less than 0.6 Exudative: cancer, infection, vasculitis - Pleural to serum protein >0.5 - Pleural to serum LDH >0.6 Tx: underlying pathology Thoracentesis, chest tube Pleurodesis - talc or chemo to scar space Complications: take off too much fluid too quickly -> reexpansion pulmonary effusion
37
Pneumothorax
Air in the pleural space Closed PTX: COPD, TB, blunt trauma, spontaneous (thin tall male) Open PTX: penetrating trauma, iatrogenic (central line, thoracentesis) Tension PTX: open with ball valve mechanism, increasing pressure Small PTX - asx ``` Tension PTX sxs: Decrease wall movement Decreased breath sounds Increased resonance to percussion Decreased tactile fremitus hypoxemia JVD Decreased blood pressure Tracheal deviation away from side ``` Tx: less than 15%: O2 and monitoring >15% - chest tube Tension: needle decompression Recurrent - pleurodesis
38
Hemothorax
blood in the pleural space like pleural effusion presentation Complication: clotting blood -> fibrosis pleural space Dx: thoracentesis - grossly bloody Tx: O2, chest tube Tx underlying cause
39
CENTOR criteria
Strep pharyngitis ``` Cough absent +1 Exudates, tonsillar +1 Nodes- tender anterior cervical +1 Temperature +1 under 15 +1 OR over 44 -1 ``` 0-1 no treatment no cx 2-3: get cx and treat if positive 4-5: tx empirically Tx: b-lactam abx - PCN, amox
40
Ludwig angina
cellulitis of floor of mouth, extending into submandibular area Causes: dental ifnection polymicrobial - GAS, staph, Bacteroides Tx: abx I&D protect airway
41
Peritonsillar abscess
Infection between the tonsil and pharyngeal constrictors Causes: strep, S. aureus, Bacteroides Presentation: Fever, severe sore throat, muffled "hot potato" Voice Tonsil or uvula deflection to the opposite side Trismus (lockjaw) Drooling Tx: needle aspiration, I&D, abx
42
Mononucleosis
EBV ``` Presentation Fatigue 3-6 mo Sore throat malaise LAD - posterior cervical Splenomegaly Fever Tonsillar exudates ``` ``` Labs: heterophil Ab - monospot EBV serology elevated LFTs Hemolytic anemia (rare) thrombocytopenia (rare) ``` Tx: supportive no noncontact supports x3 weeks no contact sports x4 weeks
43
Viral influenza
``` Presentation: arthralgias, myalgias (severe) nasal congestion cough V/D high fevers LAD ``` Lab: rapid swab Tx: zanamivir or oseltamivir within 48 hr of sxs ppx: vaccine - takes 2-4 weeks to kick in
44
Sinusitis
associated with allergic rhinitis, barotrauma, viral infection, prolonged NG tube, asthma Bacterial causes: S. pneumo, H flu, Moraxella catarrhalis Rare spread to CNS -> meningitis Chronic - over 3 mo - obstruction (polyps, deviated septum) or anaerobic infection ``` Presentation: purulent nasal discharge maxillary toothache tendernes of affected sinus foul smell ``` ``` Tx: nasal irrigation analgesics oral decongestants intranasal steroids amox-clav, doxy, levofloxacin ``` DM - mucormycosis severe/chronic - get CT sinuses
45
Acute bronchitis
features: Cough lasting longer than five days - often productive +/- purulent sputum usually not associated with fever Dx: sputum cx not recommended CXR r/o PNA (fever, abnl V/S, abnl lung exam) Tx: supportive, usually viral
46
Causes of pneumonia in neonates
GBS | E. coli
47
Causes of pneumonia in under 5 yo
RSV S. pneumo S. aureus
48
Causes of pneumonia in 5-20 yo
S. pneumo Mycoplasma pneumoniae Chalmydophilla pneumoniae
49
Causes of pneumonia in >20 yo
``` S. pneumo Mycoplasma penumoniae Chlamydophila pneumoniae Haemophilus influenzae Influenza virus Legionella pneumophila (+ diarrhea) ```
50
Causes of pneumonia in ederly
S. pneumo Haemophilus influenzae S. aureas
51
Typical pneumonia presentation, pathogens, empiric tx
``` presentation: Fever Cough Sputum production SOB ``` CXR: lobar consolidation Pathogens: S. pneumo H flu S. aureus Tx: B-lactams
52
Atypical pneumonia presentation, pathogens, empiric tx
``` Presentation: Prolonged illness Dry cough Headache Fatigue ``` CXR: interstitial infiltrates ``` Pathogens: Mycoplasma pneumoniae Chlamydophila pneumoniae Legionella pneumophilia Chlamydophila psittaci ``` Tx: macrolides, fluoroquinolones
53
Empiric treatment for neonates with CAP
hospitalize ampicillin + gentamicin or vancomycin + gentamicin
54
empiric treatment for children with CAP
often outpt tx amox or amox-clav for typical azithromycin for atypical or pcn allergy
55
Outpatient treatment of CAP in otherwise healthy individual with no antibiotics in last 3 mo
Azithromycin or doxycycline alone
56
Outpatient treatment of CAP in patient who received antibiotics in the last three months or has chronic medical problems (DM, lung dz, immunosuppression)
b-lactam - amox or cefuroxime PLUS macrolide (azith) OR Respiratory fluoroquinolone - levo or moxi
57
Inpatient treatment for CAP
B-lactam PLUS macrolide - ceftriaxone + azithromycin | Respiratory fluoroquinolone
58
ICU treatment for CAP
b-lactam PLUS macrolide or respiratory fluoroquinolone
59
Pneumococcal vaccine
PCV-13 - conjugate - 4 doses before 2 yo PPSV-23 - polysaccharide 19-64 yo: smoker, alcoholic, chronic heart, lung, liver disease, DM Over 65, CSF leak, asplenic, cochlear implant, or immunocompromised
60
Pneumocystis jirovecii (PCP)
Immunocompromised - HIV CD4 less than 200 - Chronic glucocorticoid use Slow progression to respiratory failure CXR: diffuse, B/L interstitial infiltrates Elevated LDH Sputum with Pneumocystis on stain Tx: 21 days of TMP-SMX (IV or PO) or Pentamidine (IV) or Primaquine (PO) + clindamycin (IV or PO) steroids if pO2 less than 70 on room air or A-a gradient greater than 35
61
Primary tuberculosis
Local infection in the lung Fever +/- cough and chest pain LAD Forms granulomas with central caseous necrosis (Ghon focus) Ghon complex: Ghon focus + hilar LAD 10% untreated -> PNA or disseminated TB 90% -> latent
62
Reactivation of tuberculosis
5-10% with latent TB ``` Risk: Recent primary infection Immunosuppression DM Kidney disease Older age HIV TNF-a inhibitors ``` Lung apices ``` Features: Fever Night sweats Weight-loss Cough and hemoptysis ``` Disseminated involves: bones, CNS, GI, GU
63
Diagnosis of TB
Sputum x3 8 hours apart - Acid fast stain - AFB cx - takes 4-6 weeks, needed for susceptibility TB NAAT - rapid, but no susceptibility info
64
TB screening
PPD Interfereon gamma release assay -quantiferon TB- GOLD -T-spot Evaluates release of IFN-gamma by T cells presented with M. tuberulosis antigens positive result - previous immune response to TB Immunosuppression -> unreliable results
65
PPD positive criteria
5 mm: HIV, close contact with TB, CXR suggestive of TB, immunosuppression 10 mm: homeless, IV drug use, prison, health care, immigrants from endemic areas, DM, HD, kids under 4 15 mm: always considered positive (low risk individuals)
66
Treatment of active vs latent TB
Latent: Isoniazid daily x 9 mo OR Rifapentine + isoniazid q1 wk x3 mo Active: 2 months of RIPE then 4 mo of Rifampin + isoniazid ``` RIPE: Rifampin Isoniazid + B6 Pyrazinamide Ethambutol ```
67
Acute respiratory distress syndrome
Respiratory failure following a severe acute injury to lung -sepsis, trauma, aspiration ``` Features: Acute dyspnea and respiratory decompensation Cyanosis Tachypnea Wheezing, rales, Rhonchi ``` Dx: ABG: respiratory alkalosis Wedge pressure less than 18 (if pulm edema w/ CHF over 20) PaO2:FiO2 less than 200 (under 100 severe) CXR: diffuse pulmonary densities Tx: Admit ICU - supportive care and treat underlying cause Mechanical ventilation with low tidal volumes (minimize injury) and adequate PEEP (recruit collapse alveoli) Conservative fluids - goal CVP 4-6 mmHg Furosemide and albumin to prevent pulmonary edema Prone positioning - improves oxygenation (not survival) Minimize O2 consumption: - prevent fever - minimize anxiety and pain - limit respiratory muscle use- paralytics Transfuse blood only if Hgb below 7 - transfusion may increase risk of death in ARDS patient
68
Oxygen delivery methods
NC - 24-40% FiO2 (FiO2 increases 3% every 1L/min up to 6 L/min) Face mask- 50-60% FiO2 Non-rebreather - 60-95% FiO2 CPAP -> 80% FiO2 Mechanical vent up to 100% FiO2
69
Prevention of post operative atelectasis
Incentivive spirometry Early postop ambulation Upper airway suctioning Bronchoscopic suctioning
70
Intubation
Pre-oxygenate - 100% O2 several minutes Pretreat - Lidocaine for increased ICP - Fentanyl for pain - Atropine for secretions, prevent bradycardia Induction agents: Sedatives: etomidate, propofol, midazolam, ketamine Paralytics: succinylcholine, rocuronium Cricoid pressure (Sellick technique) ``` Placement: Watch tube pass vocal cords -Check end tidal CO2 -look for bilateral lung expansions -listen for air sounds in stomach -CXR for positioning ``` Complications: tube misplacement, aspiration, dental injuries Tracheostomy if ET tube in place for few weeks